Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Zai Lab Limited

Market Cap 1.94B 1.68B 1.55B 1.45B 2.72B 186B 2.77B 18.5B 7.16B 89.51B 7.28B 7.12B 311B P/E Ratio 2026 *
-7.79x
P/E Ratio 2027 * -9.26x
Enterprise Value 1.5B 1.3B 1.2B 1.12B 2.1B 143B 2.14B 14.28B 5.53B 69.05B 5.62B 5.5B 240B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 2.61x
Free-Float
95.17%
Yield 2026 *
-
Yield 2027 * -
1 day+2.20%
1 week+1.73%
Current month-0.28%
1 month-9.95%
3 months-7.50%
6 months-1.01%
1 week 16.26
Extreme 16.26
17.91
1 month 16.26
Extreme 16.26
21.33
Current year 15.96
Extreme 15.96
25.28
1 year 15.96
Extreme 15.96
44.34
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
178.91
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 60 31/03/2014
Director of Finance/CFO 58 06/07/2023
President 62 30/11/2022
Director TitleAgeSince
Chairman 60 31/03/2014
Director/Board Member 82 31/12/2016
Director/Board Member 74 31/12/2016
Date Insider Type Main position Quantity % Market Cap.
05-26Don

Chief Executive Officer

-87,843 0.0077%
05-26Other

Chief Executive Officer

-878,430 0.0775%
05-25Other

Chief Executive Officer

-198,570 0.0175%
Change 5-day change 1-year change 3-year change Capi.($)
+2.20%+1.73%-57.39%-36.16% 1.94B
+1.63%-2.74%+17.91%-18.90% 61.21B
+2.50%+7.58%+64.44%+216.37% 58.15B
-0.92%+28.60%+28.60%+28.60% 39.54B
+4.16%+16.25%-56.08%-64.88% 35.08B
+2.94%+1.79%+50.28%-36.20% 28.68B
+2.32%+6.51%+56.62%+73.64% 21.06B
+7.94%-3.78%+78.88%-59.81% 18.25B
-1.88%-5.07%-10.05%+93.76% 16.49B
+0.78%+0.78%+49.83%+98.01% 15.87B
Average +2.16%+1.18%+22.30%+29.44% 29.63B
Weighted average by Cap. +2.11%+1.43%+29.01%+42.98%

Financials

2026 *2027 *
Net sales 449M 389M 359M 336M 628M 42.96B 641M 4.28B 1.66B 20.71B 1.68B 1.65B 72.01B 596M 517M 476M 446M 834M 57.03B 851M 5.68B 2.2B 27.49B 2.24B 2.19B 95.58B
Net income -241M -209M -193M -181M -337M -23.07B -344M -2.3B -890M -11.12B -904M -885M -38.66B -156M -136M -125M -117M -219M -14.98B -224M -1.49B -578M -7.22B -587M -575M -25.11B
Net Debt -443M -385M -354M -332M -621M -42.43B -633M -4.23B -1.64B -20.45B -1.66B -1.63B -71.11B -387M -336M -310M -290M -542M -37.07B -554M -3.69B -1.43B -17.87B -1.45B -1.42B -62.14B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
11/06/26 17.64 $ +2.20% 1,004,602
10/06/26 17.26 $ +3.66% 1,171,343
09/06/26 16.65 $ +1.03% 1,380,829
08/06/26 16.48 $ -0.84% 1,084,399
05/06/26 16.62 $ -4.15% 1,694,996
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
17.26USD
Average target price
33.30USD
Spread / Average Target
+92.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!